Fibrinogen Šumperk II: Dysfibrinogenemia in an individual with two coding mutations

American Journal of Hematology

Volumn 87, Issue 5, 2012, Pages 555-557

  Kotlín, Roman ^a   Suttnar, Jiří ^a   Čápová, Irena ^a   Hrachovinová, Ingrid ^a   Urbánková, Marie ^b   Dyr, Jan Evangelista ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b Sumperk Hospital   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOPEPTIDE A;

ADULT; BLEEDING; CASE REPORT; DYSFIBRINOGENEMIA; EPISTAXIS; FEMALE; FIBRINOGEN SUMPERK II; FIBRINOLYSIS; GENETIC ANALYSIS; GINGIVA BLEEDING; HUMAN; LETTER; MALE; MENORRHAGIA; NONSENSE MUTATION; PRIORITY JOURNAL; PURPURA; SKIN BRUISING; VEIN PUNCTURE;

ADULT; AFIBRINOGENEMIA; BLOOD PROTEIN ELECTROPHORESIS; CHILD; CODON, NONSENSE; FEMALE; FIBRIN; FIBRINOGENS, ABNORMAL; FIBRINOPEPTIDE A; HEMORRHAGIC DISORDERS; HETEROZYGOTE; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; POINT MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84859924586     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23162     Document Type: Letter

References (27)

1. Hanss M, Biot F. A database for human fibrinogen variants. Ann N Y Acad Sci 2001; 936: 89-90.
2. Lefebvre P, Velasco PT, Dear A, et al. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AαIVS4 + 1 G>T mutation and an AaGln328 truncation (fibrinogen Keokuk). Blood 2004; 103: 2571-2576.
3. Horellou MH, Chevreaud C, Mathieux V, et al. Fibrinogen Paris IX: A case of symptomatic hypofibrinogenemia with Bβ Y236C and Bβ IVS7-1G→C mutations. J Thromb Heamost 2006; 4: 1134-1136.
4. Brennan SO, Fellowes AP, Faed JM, George PM. Hypofibrinogenemia in an individual with 2 coding (γ82 A→G and Bβ235P→L) and 2 noncoding mutations. Blood 2000; 95: 1709-1713.
5. Wyatt J, Brennan SO, May S, George PM. Hypofibrinogenemia with compound heterozygosity for two gamma chain mutations-Gamma 82 Ala → Gly and an intron Two GT → AT splice site mutation. Thromb Heamost 2000; 84: 449-452.
6. Bollinger-Stucki B, Lord ST, Furlan M. Fibrinogen Milano XII: A dysfunctional variant containing 2 amino acid substitutions, Aα R16C and G165R. Blood 2001; 98: 351-357.
7. Pietrys D, Balwierz W, Iwaniec T, et al. Two different fibrinogen gene mutations associated with bleeding in the same family (A αGly13Glu and γGly16Ser) and their impact on fibrin clot properties: Fibrinogen Krakow II and Krakow III. Thromb Haemost 2011; 106: 558-560.
8. Kotlín R, Zichová K, Suttnar J, et al. Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy. Thromb Res 2011; 127: 277-278.
9. Gaja A, Terasawa F, Okumuna N. Hereditární dysfibrinogenemie s Aa13Gly® Glu mutací. In: Malý M, Pecka J, editors. Trombóza a hemostáza. Hradec Králové: HK Credit; 2001. p 114.
10. Lewis SD, Shields PP, Shafer JA. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. J Biol Chem 1985; 260: 10192-10199.
11. Riedel T, Suttnar J, Brynda E, et al. Fibrinopeptides A and B release in the process of surface fibrin formation. Blood 2011; 117: 1700-1706.
12. Rose T, Di Cera E. Three-dimensional modeling of thrombin-fibrinogen interaction. J Biol Chem 2002; 277: 18875-18880.
13. Gorkun OV, Veklich YI, Medved LV, et al. Role of the αC domains of fibrin in clot formation. Biochemistry 1994; 33: 6986-6997.
14. Tsurupa G, Tsonev L, Medved L. Structural organization of the fibrin(ogen) αC-domain. Biochemistry 2002; 41: 6449-6459.
15. Weisel JW, Litvinov RI. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate. Cardiovasc Hematol Agents Med Chem 2008; 6: 161-180.
16. Litvinov RI, Yakovlev S, Tsurupa G, et al. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other. Biochemistry 2007; 46: 9133-9142.
17. Weisel J. Fibrinogen and fibrin. Adv Protein Chem 2005; 70: 247-299.
18. Weisel JW, Medved L. The structure and function of the alpha C domains of fibrinogen. Ann N Y Acad Sci 2001; 936: 312-327.
19. Tsurupa G, Medved L. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) αC-domains. Biochemistry 2001; 40: 801-808.
20. Ganesh VK, Barbu EM, Deivanayagam CCS, et al. Structural and biochemical characterization of Staphylococcus aureus clumping factor B/ligand interactions. J Biol Chem 2011; 286: 25963-25972.
21. Park R, Doh HJ, An SS, et al. A novel fibrinogen variant (fibrinogen Seoul II; AαGln328Pro) characterized by impaired fibrin α-chain cross-linking. Blood 2006; 108: 1919-1924.
22. Simsek I, de Mazancourt P, Horellou MH, et al. Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes. Blood Coagul Fibrinolysis 2008; 19: 247-253.
23. Neerman-Arbez M, de Moerloose P, Bridel C, et al. Mutations in the fibrinogen alpha gene account for the majority of cases of congenital afibrinogenemia. Blood 2000; 96: 149-152.
24. Clauss A. Gerinnungsphysiologische Schnell-methode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246.
25. Kotlín R, Blažek B, Suttnar J, et al. Dysfibrinogenemia in childhood: Two cases of congenital dysfibrinogens. Blood Coagul Fibrinolysis 2010; 21: 640-648.
26. Kotlín R, Reicheltová Z, Suttnar J, et al. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: Fibrinogen Rokycany and fibrinogen Znojmo. J Thromb Thrombolysis 2010; 30: 311-318.
27. Suttnar J, Dyr JE, Fořtová H, et al. Determination of fibrinopeptides by high performance liquid chromatography. Biochem Clin Bohemoslov 1989; 18: 17-25.